Ranbaxy in licensing deal with Ethypharm, France

Ranbaxy in licensing deal with Ethypharm, France

BS Reporter / Mumbai September 18, 2006

Ethypharm India, subsidiary of leading French multinational drug
delivery company Ethypharm SA, has signed out-licensing and supply
contract agreements for two drug formulations with Ranbaxy Laboratories.
The out-licensing deal involves the fixed dose combinations of
fenofibrate micronized 160 mg, a drug for lowering triglycerides in
cases of Hyperlipidemia, and atorvastatin 10 mg, a drug formulation
widely used for manage cholesterol level. Ranbaxy will be launching this
combination product in the Indian market under the brand name Storfib.

This deal comes in quick succession after a similar deal that Ethypharm
had signed with Ranbaxy for out-licensing and supply of Tramadol
Flashtab in May this year.

The products will be supplied from Ethypharm